Search results
Results from the WOW.Com Content Network
Efinaconazole, sold under the brand name Jublia among others, is a triazole antifungal medication. It is approved for use in the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail).
Onychomycosis, also known as tinea unguium, [4] is a fungal infection of the nail. [2] Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed . [ 2 ]
[1] [2] In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. [3] It is a prodrug that is converted into ravuconazole. [1] Drugs for Neglected Diseases Initiative (DNDi) and the Japanese pharmaceutical company Eisai found that fosravuconazole works as a treatment for mycetoma, a serious condition.
Onychauxis frequently shows up clinically as discoloration, subungual hyperkeratosis, and loss of nail plate translucency. [3] It may cause pain, and over time, distal onycholysis, subungual bleeding, subungual ulceration, or an elevated risk of onychomycosis might aggravate matters. [4] [5]
Onychomycosis in every nail of the right foot. Onycholysis is a loosening of the exposed portion of the nail from the nail bed, usually beginning at the free edge and continuing to the lunula. It is frequently associated with an internal disorder, trauma, infection, nail fungi, allergy to nail enhancement products, or side effects of drugs.
Distal Subarachnoid Onychomycosis Segment to Dominate Due to High Volume of Patients in Hospitals and Clinics The dominant segment in the global onychomycosis treatment market is distal subarachnoid onychomycosis. This fungal infection affects the nail bed and the base of the nail, typically beginning at the tip and gradually spreading to the ...
Doctors still require Louise to go in for an annual scan to make sure her cancer has not returned, but more than one year after her surgery, she is staying positive. "Waiting for the results will ...
Onychomycosis Benzoxaborole antifungal is for the treatment of onychomycosis of toenails. It is applied to the affected toenail once daily for 48 weeks. The major adverse effects associated with its use is the ingrowing of toenails and application site reactions including exfoliation, erythema, and dermatitis.